Maurice Jones
Medical · Siloam Springs, ARNPI 1891894630
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 25.3% of the total. Reporting peaked in 2022 at $998 and has fallen 78.0% since, to $219 in 2025.
Across 102 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$626
- Boehringer Ingelheim$584
- Novo Nordisk$426
- Abbott$185
- Sanofi-aventis U.S. LLC$156
- Bayer$74
- plus $422 from 12 others
What the payments were for
- Food & beverage$2,40397%
- Other$693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $626 |
| Boehringer Ingelheim | 33 | $584 |
| Novo Nordisk | 7 | $426 |
| Abbott | 10 | $185 |
| Sanofi-aventis U.S. LLC | 4 | $156 |
| Bayer | 4 | $74 |
| Baxter Healthcare | 1 | $69 |
| Amgen(2 entities) | 3 | $58 |
| Lilly USA, LLC | 4 | $57 |
| Exact Sciences | 3 | $51 |
| Merck | 3 | $39 |
| Dexcom, Inc. | 3 | $38 |
| Sanofi Pasteur Inc. | 1 | $28 |
| GSK | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Exeltis, USA Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,473 in reported general payments places this provider in the 75th percentile of 133 medical providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 59 | $54,627 |
| JanumetSitagliptin Phos/Metformin Hcl | 41 | $40,743 |
| XareltoRivaroxaban | 23 | $11,920 |
| JanuviaSitagliptin Phosphate | 15 | $8,649 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $6,066 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 52 | $5,006 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,598 |
| Atorvastatin Calcium | 325 | $1,193 |
| Mirtazapine | 27 | $1,150 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $1,136 |
| Pantoprazole Sodium | 107 | $923 |
| Rosuvastatin Calcium | 33 | $634 |
| Verapamil ErVerapamil Hcl | 15 | $597 |
| Metformin Hcl | 135 | $553 |
| Omeprazole | 65 | $524 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $626 | $57,22570 claims |
| MerckJanumet, Januvia | $39 | $49,39256 claims |
| Johnson & JohnsonXarelto | $14 | $11,92023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 133 medical providers in Arkansas.
Other medical in Siloam Springs
- Megan AlbersSiloam Springs$1K
- Matthew ReynoldsRussellville$207K
- Tara BrunerSearcy$16K
- Dallas BondhusHot Springs$15K
- Douglas ClarkLittle Rock$14K
- Alexandra SanromaLittle Rock$11K
- Caleb MasonSearcy$9K
- Katherine McCradyLittle Rock$9K
- Bailey PollockLittle Rock$9K
- Hannah BreauLittle Rock$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.